Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2022 | 1 |
2023 | 0 |
Search Results
2
results
Results by year
Page 1
Increased Soluble PD-1 Predicts Response to Nivolumab plus Ipilimumab in Melanoma.
Cancers (Basel). 2022 Jul 9;14(14):3342. doi: 10.3390/cancers14143342.
Cancers (Basel). 2022.
PMID: 35884403
Free PMC article.
Inflammatory Cytokines and ctDNA Are Biomarkers for Progression in Advanced-Stage Melanoma Patients Receiving Checkpoint Inhibitors.
Pedersen JG, Madsen AT, Gammelgaard KR, Aggerholm-Pedersen N, Sørensen BS, Øllegaard TH, Jakobsen MR.
Pedersen JG, et al.
Cancers (Basel). 2020 May 30;12(6):1414. doi: 10.3390/cancers12061414.
Cancers (Basel). 2020.
PMID: 32486146
Free PMC article.
Item in Clipboard
Cite
Cite